TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
TECH

Bio-Techne Corp

Healthcare · Biotechnology

72.40$ -0.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

Bio-Techne Corp (TECH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 95 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow TECH
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
59 83 81 75 64 84 41 98 28 82 87 95 292
29 28 27 28 28 27 28 27 24 25 24 24 97
10 26 8.1 7.1 10 15 11 4.6 12 14 10 5.2 41
2.1 19 1.3 -10 -9.7 12 -12 22 -43 43 -4.1 22 18
14 15 16 18 9.2 6.8 10 4.9 5.4 5.9 9.1 8.5 29
-154 -24 -16 -8.8 -22 -5.0 -8.9 0.4 0.6 -5.9 -5.8 -7.1 -18
13 13 13 13 13 13 13 12 12 12 13 12 50
-20 -80 -0.2 -0.4 -76 -100 -100 0.0 0.0 0.0 -42 -42
-19 0.0 30 16 -46 -40 -60 0.0 -146
72 -81 -52 -60 -12 -84 -68 -90 -44 -49 -43 -33 -169
-32 -19 9.8 12 36 -10.0 -37 22 -17 28 37 55 103
46 68 65 58 55 78 31 93 22 76 78 87 263

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?